| Name | Title | Contact Details |
|---|
We`re the source for dependable, durable and beautiful commercial resilient flooring — an outstanding, high quality product line that`s matched only by our uncompromising service. Our expert pros work in partnership with you, delivering the insights, enthusiasm and collaboration to help you meet deadlines and exceed expectations. Since 1921, that`s been more than our mission — it`s been our promise. When your reputation is on the line, we deliver for you.
BAMA SEA PRODUCTS Inc is a Saint Petersburg, FL-based company in the Manufacturing sector.
Vaisala has been predicting the unpredictable for 85 years. We are a global leader in weather, environmental and industrial measurements, and our technologies can be found in demanding environments from hospitals, national parks and data centers to airports and wind farms all over the world, and beyond, as even the Mars Rovers Curiosity and Perseverance are equipped with our sensors.
Ne-Mo's Bakery Inc is a Escondido, CA-based company in the Manufacturing sector.
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company`s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe™. CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the SAVVE U.S. pivotal study and the company is currently waiting for regulatory approval to begin the TAVVE first-in-human trial for enVVe.